pancreatic cancer Archives

TGen, HonorHealth study new therapy for pancreatic cancer


Patients with advanced pancreatic cancer now have access to the new FDA approved drug, Onivyde, that produced significant overall survival rates in an international clinical study conducted in part by researchers at HonorHealth Research Institute and the Translational Genomics Research Institute (TGen). “Results from our clinical trial research showed a patient survival rate of nearly… Read More →

PurpleLight raises awareness of pancreatic cancer


Pancreatic cancer is currently the fourth-leading cause of cancer related deaths in the country and is expected to become the second by 2020.  The Phoenix affiliate of the Pancreatic Cancer Action Network, a nonprofit, patient-based advocacy organization, is trying to raise awareness about one of the nation’s deadliest cancers with its upcoming PurpleLight on Oct. 25 in Phoenix. The… Read More →

TGen finds genes linked to pancreatic cancer survival


A study by the Translational Genomics Research Institute (TGen) and other major research institutes, found a new set of genes that can indicate improved survival after surgery for patients with pancreatic cancer. The study also showed that detection of circulating tumor DNA in the blood could provide an early indication of tumor recurrence. In conjunction with the… Read More →

TGen begins Zebrafish pancreatic cancer studies


For more than a decade, a glassy striped fish smaller than a door key has proved an important model organism in scientific research. Named for the uniform horizontal stripes on the side of its body, the zebrafish is a tiny creature that packs a punch in terms of biological similarities with the human.Today, scientists at… Read More →

Pancreatic cancer drug successfully tested by TGen


A clinical trial conducted by researchers at the Virginia G. Piper Cancer Center Clinical Trials, a partnership between Scottsdale Healthcare and the Translational Genomics Research Institute (TGen), showed that a new drug called MM-398, given in combination with 5-flourouracil (5FU) and leucovorin, produced a significant overall survival rate in patients with advanced, previously-treated pancreatic cancer.… Read More →

TGen’s Von Hoff inducted into Joshua Lederberg Society


Dr. Daniel D. Von Hoff, Distinguished Professor and Physician-In-Chief of the Translational Genomics Research Institute (TGen), was inducted into the Joshua Lederberg Society for his work in developing the drug Abraxane for advanced pancreatic cancer patients. The Lederberg Society is named for the late Dr. Joshua Lederberg, a Nobel Prize laureate and leader in bacterial… Read More →

TGen, Ventana announce research collaboration


The Translational Genomics Research Institute (TGen) and Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced a collaborative research agreement to discover and develop diagnostic markers for treating cancer. The two Arizona-based institutions will leverage each other’s expertise in discovery and diagnostic product development, bringing innovative cancer diagnostic tests to patients.… Read More →

Foundation donates $500,000 for TGen research

by in Bioscience | Featured | Healthcare

The Seena Magowitz Foundation has donated $500,000 from two charity golf tournaments dedicated to supporting pancreatic cancer research at the Translational Genomics Research Institute (TGen). Past donations from the Seena Magowitz Foundation have helped fund significant scientific research that is making a difference in the lives of pancreatic cancer patients and their families. In January,… Read More →

Yankees’ GM supports TGen Research

Tony Pena, Brian Cashman

A top official of the New York Yankees whose father passed from pancreatic cancer has joined a prestigious national panel organized by the Translational Genomics Research Institute (TGen) to fight this aggressive disease. Brian Cashman, Senior Vice President and General Manager of the vaunted Yankees Major League Baseball franchise, has joined TGen’s National Advisory Council… Read More →

TGen, Scottsdale Healthcare study may help pancreatic cancer patients

clinical research advantage - vaccines
by in Business News | Healthcare

A multi-center Phase III clinical trial demonstrates that Abraxane (nab-paclitaxel) plus gemcitabine is the first combination of cancer drugs to extend survival of late-stage pancreatic cancer patients compared to standard treatment. The MPACT (Metastatic Pancreatic Adenocarcinoma Clinical Trial) study was led by physicians from Scottsdale Healthcare’s Virginia G. Piper Cancer Center Clinical Trials, a partnership… Read More →

TGen, Scottsdale Healthcare lead pancreatic cancer study

by in Business News | Healthcare | Tech

A new cancer drug combination demonstrated significant improvement in overall survival of late-stage pancreatic cancer patients compared to those receiving standard treatment, according to results of a Phase III clinical trial led by physicians from Scottsdale Healthcare’s Virginia G. Cancer Center Clinical Trials, a partnership with the Translational Genomics Research Institute (TGen). Physicians at the… Read More →

Vestar's Hanley, 70, Dies Of Pancreatic Cancer

Lee Hanley - Vestar
by in Business News

Lee T. Hanley, CEO of  Vestar Development, one of the largest privately held shopping center companies in the Western U.S., died Sunday. He was 70. The cause was pancreatic cancer. Hanley spent more than three decades in the industry and was regarded by many as an icon in the development community. Under his leadership, Vestar,… Read More →